Barcelona, Spain

Gal-la Pericot Mohr


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gal-la Pericot Mohr: Innovator in Pharmaceutical Compositions

Introduction

Gal-la Pericot Mohr is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained release compositions. His work focuses on innovative solutions for medical treatments, showcasing his dedication to improving patient care.

Latest Patents

Gal-la Pericot Mohr holds a patent for a sustained release tablet comprising micronized tolcapone. This invention is aimed at the prevention and/or treatment of transthyretin-associated amyloidosis. The patent details a method for administering an effective amount of the tablet to subjects in need, along with a process for its manufacture. This advancement represents a crucial step in addressing a challenging medical condition.

Career Highlights

Throughout his career, Gal-la Pericot Mohr has demonstrated a commitment to innovation in biotechnology. His work at Som Innovation Biotech, S.L. has positioned him as a key player in the pharmaceutical industry. His expertise in developing effective drug formulations has garnered attention and respect among his peers.

Collaborations

Gal-la has collaborated with talented individuals such as Anna Nardi Ricart and Josep Maria Suñé Negre. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Gal-la Pericot Mohr is a distinguished inventor whose work in pharmaceutical compositions has the potential to make a significant impact on the treatment of transthyretin-associated amyloidosis. His innovative approach and dedication to research exemplify the spirit of invention in the biotechnology field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…